Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease. (Q39738826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

0 references

Agostino Chiaravalloti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Alessandro Stefani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Nicola B. Mercuri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Claudio Liguori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Giuseppe Sancesario

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Giulia Maria Sancesario

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Orazio Schillaci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Mariangela Pierantozzi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

25 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

2040-2049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-016-3417-2

2 April 2020

exact match

0 references

cites work

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

The principled control of false positives in neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Automated Talairach Atlas labels for functional brain mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Functional connectivity in the resting brain: a network analysis of the default mode hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Resting-state functional connectivity reflects structural connectivity in the default mode network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Characteristics of the default mode functional connectivity in normal ageing and Alzheimer's disease using resting state fMRI with a combined approach of entropy-based and graph theoretical measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Effects of brain amyloid deposition and reduced glucose metabolism on the default mode of brain function in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Dynamic brain functional connectivity modulated by resting-state networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

A default mode of brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

21 January 2018

PET studies in dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Investigating the functional heterogeneity of the default mode network using coordinate-based meta-analytic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Whole cortical and default mode network mean functional connectivity as potential biomarkers for mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

The brain's default network: anatomy, function, and relevance to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Default mode network connectivity in stable vs progressive mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Deciphering the molecular basis of memory failure in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3417-2

Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease

21 January 2018

1 reference

12 December 2020

Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study.

1 reference

12 December 2020

Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer's disease and other dementias.

1 reference

12 December 2020

Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study.

1 reference

12 December 2020

Diagnostic accuracy of blood and CSF lactate in identifying children with mitochondrial diseases affecting the central nervous system

1 reference

12 December 2020

Mitochondrial abnormalities in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S00259-016-3417-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27221635%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference